𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HPV vax + cervical cancer screening potentially cost effective

Book ID
120851594
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2005
Weight
138 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

HPV testing for cervical cancer screenin
HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
✍ Yvonne N. Flores; David M. Bishai; Attila LΕ‘rincz; Keerti V. Shah; Eduardo Lazca πŸ“‚ Article πŸ“… 2010 πŸ› Springer Netherlands 🌐 English βš– 261 KB

## Objective To determine the incremental costs and effects of different HPV testing strategies, when compared to Papanicolau cytology (Pap), for cervical cancer screening in Mexico. ## Methods A cost-effectiveness analysis (CEA) examined the specific costs and health outcomes associated with (1)

Cost-effectiveness of primary cytology a
Cost-effectiveness of primary cytology and HPV DNA cervical screening
✍ Peter Bistoletti; Karin SennfΓ€lt; Joakim Dillner πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 93 KB

## Abstract Because cost‐effectiveness of different cervical cytology screening strategies with and without human papillomavirus (HPV) DNA testing is unclear, we used a Markov model to estimate life expectancy and health care cost per woman during the remaining lifetime for 4 screening strategies: